Superior Therapy Response Predictions for Patients with Myelodysplastic Syndrome (MDS) Using Cellworks Singula™: Mycare-020-02

Background: Therapy selection for MDS patients is often based on information considering only cytogenetics and single molecular aberrations and ignoring other patient-specific omics data that could potentially enable more effective treatments. In turn, despite using cytogenetic and molecular-risk st...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2020-11, Vol.136 (Supplement 1), p.9-10
Hauptverfasser:	Stein, Anthony S., Watson, Drew, Nair, Prashant Ramachandran, Basu, Kabya, Ullal, Yashaswini S, Ghosh, Adity, Narvekar, Yugandhara, Grover, Himanshu, Sahu, Diwyanshu, Prakash, Annapoorna, Behura, Liptimayee, Balakrishnan, Veena, Roy, Kunal Ghosh, Rajagopalan, Swaminathan, Alam, Aftab, Parashar, Rajan, Mundkur, Nirjhar, Christie, James, Macpherson, Michele Dundas, Kapoor, Shweta, Marcucci, Guido
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!